Plex Research logo

Plex Research

AI-powered scientific intelligence for drug discovery, querying billions of biomedical data points across genomics, proteomics, and clinical trials to deliver evidence-backed target and biomarker insights.

Visit website

Overview

Plex Research is an AI-powered scientific intelligence platform purpose-built for drug discovery. Rather than relying on large language model text summarization, Plex is grounded in a proprietary biomedical knowledge graph — called the Focal Graph — containing billions of structured data points spanning genomics, proteomics, compound activity, clinical trials, and published literature. The platform transforms how pharmaceutical and biotech teams discover targets, evaluate programs, and make critical R&D decisions, delivering evidence-backed answers that are fully traceable to specific data sources and records.

Trusted by more than 40 pharmaceutical and biotech discovery teams, Plex serves scientists, computational biologists, drug developers, and executives who need reproducible, data-rich intelligence rather than plausible-sounding but unverifiable AI-generated text. The platform supports use cases ranging from early-stage target identification through portfolio-level governance decisions.

Core Platform Capabilities

  • Knowledge Graph (Focal Graph): Billions of data points from genomics, proteomics, clinical trials, compound activity databases, and literature are structured and queryable in real time, enabling direct interrogation of biological and chemical datasets rather than text search.
  • Evidence Scoring: Every answer is backed by quantified evidence evaluated across seven distinct dimensions, with full source traceability so teams can audit and reproduce results.
  • Proprietary Data Integration: Internal experimental data can be integrated into the platform under strict confidentiality protocols, ensuring that proprietary information never leaves the customer's environment.
  • Chemical Intelligence Tooling: Built-in structure-aware compound analysis capabilities allow users to query and interpret chemical datasets alongside biological data.
  • Multi-Omics Integration: Plex integrates genomic, proteomic, and Perturb-seq signatures to rank targets and biomarkers by evidence strength across patient populations and disease contexts.

How Plex Works

  • Ask a scientific question: Users pose any question — from target identification to biomarker discovery — and Plex understands both biological and chemical context.
  • Knowledge graph search: Billions of data points spanning genomics, proteomics, compound activity, and clinical data are integrated and scored in real time.
  • Structured, actionable answers: Results are returned with confidence scores, source citations, and chemical intelligence tooling for structure-aware analysis, ready for R&D and governance decisions.

Key Use Cases

  • Target Identification: Discover novel therapeutic targets supported by multi-omics evidence integration across disease areas.
  • Biomarker Discovery: Identify predictive and prognostic biomarkers across patient populations, with prioritized candidates, predictive power estimates, validation status, and recommended assay strategies for clinical translation.
  • Target Evaluation: Score and compare targets across seven evidence dimensions — biology, genetics, druggability, safety, clinical signal, competitive landscape, and proprietary data concordance — before committing capital.
  • Competitive Intelligence: Real-time landscape analysis of the competitive environment to inform portfolio strategy.
  • For Scientists: Accelerate hypothesis generation with structured, evidence-backed analysis.
  • For Developers: Integrate Plex's knowledge graph directly into computational pipelines via API.
  • For Executives: Make faster, more confident portfolio decisions with structured target and program evaluation.

Scientific Outputs and Deliverables

  • Target Evaluation Report: A structured assessment across seven dimensions including biology, genetics, druggability, safety, clinical signal, competitive landscape, and proprietary data concordance, exportable as a PDF for governance and decision-making workflows.
  • Biomarker Panel: Prioritized candidate biomarkers with predictive power estimates, validation status, and recommended assay strategies, covering predictive, prognostic, and companion diagnostic applications.
  • Competitive Intelligence Reports: Real-time landscape analysis structured for portfolio-level decision-making.

How Plex Differs from Literature-Based AI Tools

  • Built on billions of structured data points from biomedical databases — not trained on text alone.
  • Queries genomic, proteomic, clinical, and chemical datasets directly rather than searching published literature.
  • Every answer is traceable to specific data sources and records, ensuring reproducibility.
  • Outputs are reproducible and evidence-scored, unlike LLM-generated answers that can vary between queries.
  • Integrated chemical intelligence tooling enables compound-level analysis that text-based tools cannot perform.

Plex Research's mission is to increase the world's ability to discover cures by leveraging massive amounts of biomedical data and making that intelligence accessible and actionable for the full spectrum of drug discovery teams — from bench scientists to R&D executives.